Predilife (XPAR:ALPRE) Additional Paid-In Capital : €12.74 Mil(As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Predilife Additional Paid-In Capital?

Predilife's quarterly additional paid-in capital stayed the same from Jun. 2022 (€12.74 Mil) to Dec. 2022 (€12.74 Mil) and stayed the same from Dec. 2022 (€12.74 Mil) to Jun. 2023 (€12.74 Mil).

Predilife's annual additional paid-in capital increased from Dec. 2020 (€11.61 Mil) to Dec. 2021 (€12.74 Mil) but then stayed the same from Dec. 2021 (€12.74 Mil) to Dec. 2022 (€12.74 Mil).

Predilife Additional Paid-In Capital Historical Data

The historical data trend for Predilife's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Predilife Additional Paid-In Capital Chart

Predilife Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Additional Paid-In Capital

Get a 7-Day Free Trial

6.54

7.89

11.61

12.74

Predilife Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Additional Paid-In Capital	Get a 7-Day Free Trial									11.61	12.74	12.74	12.74	12.74

Predilife Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Predilife Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Predilife's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Predilife (XPAR:ALPRE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Predilife SA (XPAR:ALPRE) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

114 rue Edouard Vaillant Espace Maurice Tubiana, Villejuif, Paris, FRA, 94800

Website

https://www.predilife.com

Predilife SA develops solutions of predictive medicine combining proven medical techniques (genetic tests, medical imaging) and mathematical models using a large number of statistical data that could allow each individual to define his risk profile for the occurrence of a large number of serious diseases. The company markets its Mammorisk personalized breast cancer screening solution in Europe and the United States.

Predilife (XPAR:ALPRE) Headlines

No Headlines